EA201891474A1 - Капсулирование ультрастабильных аналогов инсулина в полимерных расплавах - Google Patents
Капсулирование ультрастабильных аналогов инсулина в полимерных расплавахInfo
- Publication number
- EA201891474A1 EA201891474A1 EA201891474A EA201891474A EA201891474A1 EA 201891474 A1 EA201891474 A1 EA 201891474A1 EA 201891474 A EA201891474 A EA 201891474A EA 201891474 A EA201891474 A EA 201891474A EA 201891474 A1 EA201891474 A1 EA 201891474A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- insulin
- wild
- position corresponding
- type
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Композиция инсулина включает аналог инсулина и полимерную смесь. Аналог инсулина содержит цистеиновые замены в положениях B4 и A10 (с образованием цистина B4-A10) и одну или несколько дополнительных замен, выбранных из группы, состоящей из соединяющего домена из 5-11 аминокислот между доменами A и B аналога инсулина; замены не являющейся бета-разветвленной аминокислотой в положении, соответствующем положению A8 инсулина дикого типа; не являющейся бета-разветвленной кислотной или полярной боковой цепи в положении, соответствующем положению A14 инсулина дикого типа; модификации галогеном ароматического кольца Phe в положении, соответствующем положению B24 инсулина дикого типа в орто-положении ароматической боковой цепи; и замены лизина в положении, соответствующем положению B29 инсулина дикого типа, аргинином, глутаминовой кислотой, аланином, валином, изолюцином, лейцином, аминопропионовой кислотой, аминомасляной кислотой или норлейцином. Аналог инсулина совместим с процессом производства, который включает один или более этапов в интервале температур 90-120°C. Капсулированный аналог инсулина необязательно может содержать свободный ПЭГ или быть ПЭГилированным. Смесь капсулированного в полимер инсулина можно отливать в виде микроигольного пластыря для местного введения или в виде микропеллет для подкожной инъекции.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562387459P | 2015-12-23 | 2015-12-23 | |
PCT/US2016/068572 WO2017112952A1 (en) | 2015-12-23 | 2016-12-23 | Encapsulation of ultra-stable insulin analogues with polymer melts |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201891474A1 true EA201891474A1 (ru) | 2018-12-28 |
EA039101B1 EA039101B1 (ru) | 2021-12-03 |
Family
ID=59091272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201891474A EA039101B1 (ru) | 2015-12-23 | 2016-12-23 | Капсулирование ультрастабильных аналогов инсулина в полимерных расплавах |
Country Status (15)
Country | Link |
---|---|
US (1) | US11583572B2 (ru) |
EP (1) | EP3393498A4 (ru) |
JP (1) | JP7203415B2 (ru) |
KR (1) | KR20180097517A (ru) |
CN (1) | CN108430493A (ru) |
AU (2) | AU2016377786A1 (ru) |
BR (1) | BR112018012814A2 (ru) |
CA (1) | CA3009187A1 (ru) |
EA (1) | EA039101B1 (ru) |
HK (1) | HK1255634A1 (ru) |
IL (1) | IL259899A (ru) |
MX (1) | MX2018006103A (ru) |
PH (1) | PH12018500966A1 (ru) |
SG (1) | SG11201803911PA (ru) |
WO (1) | WO2017112952A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR111122A1 (es) * | 2017-03-07 | 2019-06-05 | Univ Case Western Reserve | Análogos de insulina de cadena única estabilizados por un cuarto puente disulfuro |
US20210371489A1 (en) * | 2018-09-21 | 2021-12-02 | Case Western Reserve University | Site 2 single-chain insulin analogues |
US20220002373A1 (en) * | 2018-11-19 | 2022-01-06 | Case Western Reserve University | Single-chain insulin analogues with poly-alanine c-domain sub-segments |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005054291A1 (en) | 2003-12-03 | 2005-06-16 | Novo Nordisk A/S | Single-chain insulin |
WO2007081824A2 (en) * | 2006-01-06 | 2007-07-19 | Case Western Reserve University | Fibrillation resistant proteins |
EP1991575A1 (en) | 2006-02-21 | 2008-11-19 | Novo Nordisk A/S | Single-chain insulin analogues and pharmaceutical formulations thereof |
BRPI0911571A2 (pt) * | 2008-04-22 | 2018-04-03 | Univ Case Western Reserve | método para tratar um mamífero, análogo de insulina, ácido nucléico e célula hospedeira |
EP2982687A1 (en) * | 2008-07-31 | 2016-02-10 | Case Western Reserve University | Halogen-stabilized insulin |
JP5973427B2 (ja) | 2010-06-23 | 2016-08-23 | ノヴォ ノルディスク アー/エス | 追加のジスルフィド結合を含有するインスリン類似体 |
CN102985440B (zh) * | 2010-06-23 | 2016-10-26 | 诺沃-诺迪斯克有限公司 | 包含额外的二硫键的胰岛素衍生物 |
WO2013010048A2 (en) * | 2011-07-13 | 2013-01-17 | Case Western Reserve University | Non-standard insulin analogues |
US9101547B2 (en) * | 2011-08-04 | 2015-08-11 | Nano And Advanced Materials Institute Limited | Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery |
KR20150021011A (ko) * | 2011-10-27 | 2015-02-27 | 케이스 웨스턴 리저브 유니버시티 | 초고도 농축된, 속효성 인슐린 유사체 제형 |
CA2890719C (en) | 2012-11-05 | 2023-02-14 | Case Western Reserve University | Long-acting single-chain insulin analogues |
WO2015010927A1 (en) * | 2013-07-24 | 2015-01-29 | Novo Nordisk A/S | Pharmaceutical composition for oral insulin administration comprising a tablet core and an anionic copolymer coating |
CN107108716A (zh) * | 2014-10-06 | 2017-08-29 | 卡斯西部储备大学 | 双相性单链胰岛素类似物 |
AR111122A1 (es) * | 2017-03-07 | 2019-06-05 | Univ Case Western Reserve | Análogos de insulina de cadena única estabilizados por un cuarto puente disulfuro |
-
2016
- 2016-12-23 MX MX2018006103A patent/MX2018006103A/es unknown
- 2016-12-23 CN CN201680075661.8A patent/CN108430493A/zh active Pending
- 2016-12-23 SG SG11201803911PA patent/SG11201803911PA/en unknown
- 2016-12-23 AU AU2016377786A patent/AU2016377786A1/en not_active Abandoned
- 2016-12-23 JP JP2018524288A patent/JP7203415B2/ja active Active
- 2016-12-23 US US16/065,596 patent/US11583572B2/en active Active
- 2016-12-23 KR KR1020187013250A patent/KR20180097517A/ko unknown
- 2016-12-23 WO PCT/US2016/068572 patent/WO2017112952A1/en active Application Filing
- 2016-12-23 EA EA201891474A patent/EA039101B1/ru unknown
- 2016-12-23 BR BR112018012814A patent/BR112018012814A2/pt not_active Application Discontinuation
- 2016-12-23 EP EP16880161.1A patent/EP3393498A4/en active Pending
- 2016-12-23 CA CA3009187A patent/CA3009187A1/en active Pending
-
2018
- 2018-05-04 PH PH12018500966A patent/PH12018500966A1/en unknown
- 2018-06-07 IL IL259899A patent/IL259899A/en unknown
- 2018-11-20 HK HK18114770.7A patent/HK1255634A1/zh unknown
-
2021
- 2021-10-07 AU AU2021245176A patent/AU2021245176A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3393498A4 (en) | 2019-08-07 |
BR112018012814A2 (pt) | 2018-12-04 |
CA3009187A1 (en) | 2017-06-29 |
EA039101B1 (ru) | 2021-12-03 |
US11583572B2 (en) | 2023-02-21 |
MX2018006103A (es) | 2018-09-21 |
WO2017112952A1 (en) | 2017-06-29 |
WO2017112952A4 (en) | 2017-08-17 |
SG11201803911PA (en) | 2018-07-30 |
US20210162014A1 (en) | 2021-06-03 |
AU2021245176A1 (en) | 2021-11-04 |
PH12018500966A1 (en) | 2018-11-19 |
CN108430493A (zh) | 2018-08-21 |
HK1255634A1 (zh) | 2019-08-23 |
JP2019503339A (ja) | 2019-02-07 |
IL259899A (en) | 2018-07-31 |
AU2016377786A1 (en) | 2018-06-14 |
JP7203415B2 (ja) | 2023-01-13 |
KR20180097517A (ko) | 2018-08-31 |
EP3393498A1 (en) | 2018-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201891474A1 (ru) | Капсулирование ультрастабильных аналогов инсулина в полимерных расплавах | |
EA201992247A1 (ru) | Быстрая и контролируемая доставка композиций с восстановленным эффектом антуража | |
PE20180158A1 (es) | Coagonistas de los receptores de glucagon y de glp-1 | |
MX2017006016A (es) | Composiciones conjugadas de xten direccionadas y metodos para producir las mismas. | |
AR105485A1 (es) | Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo | |
AR111122A1 (es) | Análogos de insulina de cadena única estabilizados por un cuarto puente disulfuro | |
ECSP13013115A (es) | Composiciones que contienen, métodos que involucran, y usos de derivados de dolastatina unidos a aminoácidos no naturales | |
NZ764889A (en) | Composition for treating diabetes mellitus comprising insulin and a glp-1/glucagon dual agonist | |
MX361681B (es) | Composiciones de proteína estabilizadas basadas en alcanos semifluorados. | |
EA201590525A1 (ru) | Слитые белки для лечения метаболического синдрома | |
BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
EA201391136A1 (ru) | Лиофилизированные составы | |
MX2014011614A (es) | Fragmentos y proteinas nutritivas con fenilalanina baja o nula y metodos. | |
EA201401211A1 (ru) | Улучшенные варианты фермента химозина | |
NZ579566A (en) | Modified fgf-21 polypeptides and their uses | |
CL2020002574A1 (es) | Análogos novedosos de glp-1 | |
EA201991023A1 (ru) | Фармацевтическая композиция для парентерального введения, содержащая карглумовую кислоту | |
HRP20161703T1 (hr) | Formulacije kaspofungin acetata | |
EA201590601A1 (ru) | Применение pedf-производных полипептидов для лечения остеоартрита | |
EA201490032A1 (ru) | Лиофилизированные препараты fgf-18 | |
EA202090404A1 (ru) | Универсальный способ презентирования циклического пептида на белковой структуре | |
UY37490A (es) | Análogos de insulina de acción rápida de estabilidad mejorada. | |
JOP20180052A1 (ar) | تغليف مضاهئات إنسولين فائقة الاستقرار داخل فلزات بوليمرية | |
RU2013146452A (ru) | Инъекционный или инфузионный раствор триазавирина для лечения вирусных инфекций | |
MX362058B (es) | Péptido pntx(19) sintético, composición farmacéutica y uso. |